Interethnic Differences in Serum Lipids
African Americans generally have a healthier lipid profile (lower triglycerides and higher high-density lipoprotein cholesterol concentration) compared with those of other ethnicities. Paradoxically, African Americans do not experience a decreased risk of the cardiometabolic diseases that serum lipids are expected to predict. This review explores this mismatch between biomarker and disease among African ancestry individuals by investigating the presence of interethnic differences in the biological relationships underlying the serum lipids –disease association. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 17, 2017 Category: Cardiology Authors: Amy R. Bentley, Charles N. Rotimi Tags: Review Source Type: research
Evaluating Health of Emerging Economies Through the Eyes of Heart Valve Disease in the Transcatheter Era
China and India are the 2 fastest growing major world economies. However, they suffer from great differences in health policies, demographics, and rates of population growth. Whereas China has seen a steep decline in rheumatic heart disease (RHD) and a rise in life expectancy, India continues to suffer from a significant burden of RHD due to insufficient distribution of economic prosperity to health care, denser population, and ineffective application of World Health Organization RHD prevention guidelines. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - April 19, 2017 Category: Cardiology Authors: Sameer Arora, Cassandra J. Ramm, Amol A. Bahekar, John P. Vavalle Tags: Review Source Type: research
Youth Engagement for NCD Prevention Policies
Youth are a vital component of global society. Youth, who are considered by the World Health Organization (WHO) to be anyone between the ages of 15 and 24 years, make up roughly one-fourth of the world's living population [1,2]. Currently, this particular age cohort is the largest in history and in turn has the ability to serve as a catalyst for change that will shape the future of the world's social, economic, and health enterprises [2]. In India, where youth make up 19% of the population, this is especially true and should be acknowledged by the country's government, especially when considering health. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - April 19, 2017 Category: Cardiology Authors: Ishu Kataria, Jennifer L. Cruz Tags: Viewpoint Source Type: research
Is TAVR Ready for the Global Aging Population?
The emergence of the global pandemic of chronic diseases necessitates critical assessment of interventions that can be targeted at both the individual and population levels. Among cardiovascular diseases, the increasing prevalence of valvular heart diseases such as aortic stenosis parallels the rising burden of atherosclerotic cardiovascular diseases. As an alternative to surgical aortic valve replacement, technological innovation has allowed development of minimally invasive transcatheter aortic valve replacement (TAVR). (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - April 19, 2017 Category: Cardiology Authors: Travis Bergmann, Partho P. Sengupta, Jagat Narula Tags: Review Source Type: research
20-Year Trend of Cardiovascular Disease Risk Factors
The World Health Organization and the Government of India have set targets to reduce burden of noncommunicable diseases. Information on population level trend of risk factors would provide insights regarding the possibility of achieving them. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - April 11, 2017 Category: Cardiology Authors: Dorairaj Prabhakaran, Ambuj Roy, Pradeep A. Praveen, Lakshmy Ramakrishnan, Ruby Gupta, Ritvik Amarchand, Dimple Kondal, Kalpana Singh, Meenakshi Sharma, Deepak Kumar Shukla, Nikhil Tandon, Kolli Srinath Reddy, Anand Krishnan Tags: Original Research Source Type: research
Genetic Effects on the Correlation Structure of CVD Risk Factors
Plasma concentration of plasminogen activator inhibitor-1 (PAI-1) is highly correlated with several cardiovascular disease (CVD) risk factors. It also plays a direct role in CVD, including myocardial infarction and stroke, by impeding the dissolution of thrombi in the blood. Insofar as PAI-1 links CVD's risk factors to its endpoints, genetic variants modulating the relationship between PAI-1 and risk factors may be of particular clinical and biological interest. The high heritability of PAI-1, which has not been explained by genetic association studies, may also, in large part, be due to this relationship with CVD risk fac...
Source: CVD Prevention and Control - April 10, 2017 Category: Global & Universal Authors: Nuri Kodaman, Rafal S. Sobota, Folkert W. Asselbergs, Matthew T. Oetjens, Jason H. Moore, Nancy J. Brown, Melinda C. Aldrich, Scott M. Williams Tags: Review Source Type: research
Neurological Complications in Subjects With Sickle Cell Disease or Trait
Sickle cell disease (SCD) is the most common inherited single-gene disorder in world, and Africa houses the majority of the patients. In fact, in 2010, 79% of newborns with SCD were in Africa, and this number is expected to increase to 88% by 2050 [1]. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - April 1, 2017 Category: Global & Universal Authors: Guida Landour é, Lassana Cissé, Boubacar A. Touré, Abdoulaye Yalcouyé, Toumany Coulibaly, Mamadou Karambé, Adama S. Sissoko, Thomas Coulibaly, Ambroise Wonkam, Cheick O. Guinto, The H3Africa Consortium Tags: Brief Report Source Type: research
Sex, Ethnicity, and CVD Among Women of African Descent
Cardiovascular disease (CVD) is the leading cause of death for both men and women globally, responsible for approximately 17.9 million deaths each year [1]. CVDs disproportionately affect women and men of color. Black women are more likely to succumb to CVDs than all other Americans and have high rates of other non-communicable diseases such as diabetes, obesity, chronic kidney disease, and hypertension [2-4]. These comorbid diseases significantly increase the chances of black women developing CVDs within a lifetime, adding to the disparity in this population. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 25, 2017 Category: Cardiology Authors: Whitney L. Barfield, Cheryl Anne Boyce Tags: Editorial Viewpoint Source Type: research
The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of RHD
Rheumatic heart disease (RHD) is a preventable non-communicable condition that disproportionately affects the world's poorest and most vulnerable. The World Heart Federation Roadmap for improved RHD control is a resource designed to help a variety of stakeholders raise the profile of RHD nationally and globally, and provide a framework to guide and support the strengthening of national, regional and global RHD control efforts. The Roadmap identifies the barriers that limit access to and uptake of proven interventions for the prevention and control of RHD. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 20, 2017 Category: International Medicine & Public Health Authors: Benjamin Palafox, Ana Olga Mocumbi, R. Krishna Kumar, Sulafa K.M. Ali, Elizabeth Kennedy, Abraham Haileamlak, David Watkins, Kadia Petricca, Rosemary Wyber, Patrick Timeon, Jeremiah Mwangi Tags: World Heart Federation Roadmap Source Type: research
The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of Rheumatic Heart Disease
Rheumatic heart disease (RHD) is a preventable non-communicable condition that disproportionately affects the world's poorest and most vulnerable. The World Heart Federation Roadmap for improved RHD control is a resource designed to help a variety of stakeholders raise the profile of RHD nationally and globally, and provide a framework to guide and support the strengthening of national, regional and global RHD control efforts. The Roadmap identifies the barriers that limit access to and uptake of proven interventions for the prevention and control of RHD. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 19, 2017 Category: Global & Universal Authors: Benjamin Palafox, Ana Olga Mocumbi, R. Krishna Kumar, Sulafa K.M. Ali, Elizabeth Kennedy, Abraham Haileamlak, David Watkins, Kadia Petricca, Rosemary Wyber, Patrick Timeon, Jeremiah Mwangi Tags: World Heart Federation Roadmap Source Type: research
The Importance of Conducting Stroke Genomics Research in African Ancestry Populations
There is a pronounced health disparity in the burden of stroke between African and European ancestry populations. Compared to European Caucasians, African ancestry populations experience an increased incidence of stroke, a younger age of onset, worse prognosis, and a stronger propensity to the hemorrhagic form of stroke. The contributors to this disparity are multifactorial, but likely include differences between populations in conventional stroke risk factors and socioeconomic factors, and the interplay between these factors and genetic background. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 19, 2017 Category: Global & Universal Authors: Huichun Xu, Braxton D. Mitchell, Emmanuel Peprah, Steven J. Kittner, John W. Cole Tags: Review Source Type: research
The Word Heart Federation Roadmap for Nonvalvular Atrial Fibrillation
The World Heart Federation has undertaken an initiative to develop a series of Roadmaps to promote development of national policies and health systems approaches, and to identify potential roadblocks on the road to effective prevention, detection, and management of cardiovascular disease in low-and middle-income countries (LMICs) and develop strategies for overcoming these. This Roadmap focuses on atrial fibrillation (AF). AF is the most common, clinically significant arrhythmia and, among other clinical outcomes, is associated with increased risk of stroke. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 19, 2017 Category: Global & Universal Authors: Adrianna Murphy, Amitava Banerjee, G ünter Breithardt, A. John Camm, Patrick Commerford, Ben Freedman, J. Antonio Gonzalez-Hermosillo, Jonathan L. Halperin, Chu-Pak Lau, Pablo Perel, Denis Xavier, David Wood, Xavier Jouven, Carlos A. Morillo Tags: World Heart Federation Roadmap Source Type: research
The Health Systems Barriers and Facilitators for RHD Prevalence
Rheumatic heart disease (RHD) is an important and preventable cause of cardiovascular disease. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 15, 2017 Category: International Medicine & Public Health Authors: Annesinah H. Moloi, Sumaya Mall, Mark E. Engel, Renae Stafford, Zhang Wan Zhu, Liesl J. Z ühlke, David A. Watkins Tags: Original Research Source Type: research
Rheumatic Heart Disease Epidemiology and Health Systems Barriers and Facilitators
Rheumatic heart disease (RHD) is an important and preventable cause of cardiovascular disease. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 14, 2017 Category: Cardiology Authors: Annesinah H. Moloi, Sumaya Mall, Mark E. Engel, Renae Stafford, Zhang Wan Zhu, Liesl J. Zuhlke, David A. Watkins Tags: Original Research Source Type: research
Identifying Female Community Health Volunteers' Understanding and Motivations About Blood Pressure Control
Health literacy and attitudes of female community health volunteers (FCHV) toward hypertension management in the context of Nepal are not well understood. Therefore, it is important to explore the potential for the effectiveness for blood pressure screening and perceptions on their likely ability to promote a blood pressure reduction at community level. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - March 12, 2017 Category: Global & Universal Authors: Dinesh Neupane, Craig S. McLachlan, Shiva R. Mishra, Per Kallestrup Tags: Original Research Source Type: research
